Navigation Links
FDA approves IND on Lead Product M6G

CAMBRIDGE, England, 26th April 2007 - CeNeS Pharmaceuticals plc (LSE: CEN), the Cambridge based biopharmaceutical company, today announces that the United States Food and Drug Administration (FDA) has approved its Investigational New Drug (IND) application for the clinical development of morphine-6-glucuronide (M6G), its novel drug for the treatment of post-operative pain. Earlier this year, CeNeS announced results of a Phase III study of M6G in Europe in over 500 patients with post-operative pain. The study demonstrated that M6G provided equivalent pain relief to morphine but induced significantly less post-operative nausea and vomiting (PONV). The opening trial under this IND will be a Phase I pharmacokinetic study in volunteers. This study is required by the FDA as is an additional pre-clinical toxicology analysis before progressing to Phase III trials. CeNeS is currently completing the protocol design of the first US Phase III trial. The filing of the IND enhances the package of data already available to potential US partners for review. Neil Clark, Chief Executive of CeNeS, said:

"The FDA's approval of our IND application for M6G is a major landmark in CeNeS' clinical development programme. North America is an attractive market for our drug candidate and M6G is clearly positioned to be a genuine alternative to standard morphine therapy."

For more information please contact: CeNeS Pharmaceuticals plc Neil Clark, CEO Tel: +44 (0)1223 266 466

JM Finn Geoff Nash Tel: +44(0) 207 628 9688

Financial Dynamics Ben Brewerton/Emma Thompson Tel: + 44 (0) 207 831 3113

About CeNeS Pharmaceuticals CeNeS is a biopharmaceutical company specialising in the development and commercialisation of drugs for pain control, sedation and other CNS disorders such as Parkinson's disease. The company is based in Cambridge, England. For further information visit the CeNeS web site: '"/>




Page: 1 2

Related medicine technology :

1. FDA approves MyocondaR IND for MAP in Crohns Disease
2. Pieris Progresses Proprietary Asthma Program: Validation of Pulmonary Delivery of Anticalin-Based Protein Product Candidate
3. NexMed Announces Completion of Patient Enrollment in Two Pivotal Phase 3 Studies for Anti-Fungal Product
4. CombinatoRx Product Candidate CRx-150 Shows Activity on DAS28 and Pain, but Not CRP
5. Publication Confirms that EpCAM, the Target for Two of Micromets Product Candidates, Is Overexpressed on Cancer Stem Cells of Certain Cancers
6. HepaLifes PBS-1 Cells for Influenza Vaccine Production Prove Superior at International Conference
7. Positive Clinical Results for DG041 Lead Product Development Highlights at deCODE R&D Event
8. PromegaExpress Expands Easy Access to Products with New Cabinet
9. Research Documents Scalable Production, Survival Following Engraftment and Positive Impact on Cardiac Function in Infarcted Rats for Gerons Human Embryonic Stem Cell-Based Therapeutic for Heart Failure
10. Three Studies Suggest Abbotts Humira (adalimumab) May Improve Work Productivity in Patients with Rheumatoid Arthritis
11. Further Statistical Analysis of the Recent Phase III trial on Lead Product M6G Shows Additional Benefits
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: FDA approves IND Lead Product
(Date:7/2/2015)... MUMBAI , July 2, 2015 ... equity stake in ZAO "Biocom" in Russia ... foray into the Russian pharmaceutical market which recorded RUB 765 ... 10 pharmaceutical markets in the world in 2014 (IMS Health). ... growth and expected to continue with this trend, projecting ...
(Date:7/2/2015)... July 2, 2015 The report ... Heterofermentative), Species (Lactobacillus, Pediococcus & Enterococcus), Enzymes (Fibre-digesting & ... to 2020", Silage Inoculants & Enzymes Market is expected ... of 4.0% from 2015 to 2020. ... spread through 194 P ages and ...
(Date:7/2/2015)... 2015 BGI gab heute bekannt, ... vom American College of Pathologists (CAP) akkreditiert ... erste klinische Next-Generation-Sequencing Labor, das in ... und somit die höchsten Standards an klinischer ... FDA - 21 CFR Part 11 konformen ...
Breaking Medicine Technology:Lupin Acquires Biocom in Russia 2Lupin Acquires Biocom in Russia 3Silage Inoculants & Enzymes Market Worth $489.05 Million by 2020 2Silage Inoculants & Enzymes Market Worth $489.05 Million by 2020 3Silage Inoculants & Enzymes Market Worth $489.05 Million by 2020 4BGI erhält Akkreditierung vom College of American Pathologists (CAP) 2
(Date:7/3/2015)... (PRWEB) , ... July 04, 2015 , ... The Harvest Hope Food Bank ... July. Four local AlignLife offices in the area of Greenville SC are making ... to be made by patients only. They are asking for donations from the public as ...
(Date:7/3/2015)... ... July 03, 2015 , ... ... its 2015 Annual Conference , the premiere continuing education and networking ... Orlando at SeaWorld in Orlando, Florida. Speakers include the leading rheumatology experts ...
(Date:7/3/2015)... ... July 03, 2015 , ... ... healthcare providers, has been retained to lead a national president recruitment ... firms in the healthcare industry, B. E. Smith has recently placed more than ...
(Date:7/3/2015)... CT (PRWEB) , ... July 03, 2015 , ... Smoothies ... home is a good blender and easily accessible, quality ingredients. Aurora Natural is proud ... smoothie for an added boost of fiber, protein, antioxidants, vitamins and minerals! , Aurora ...
(Date:7/3/2015)... ... ... First Choice Emergency Room , the largest network of independent freestanding emergency ... Director of its Frisco facility. , “We are pleased to announce that Dr. Manzanares ... Muzzarelli, Executive Medical Director of First Choice Emergency Room. , Dr. Manzanares received ...
Breaking Medicine News(10 mins):Health News:Greenville Area AlignLife Offices to do a Thanksgiving in July Food Drive 2Health News:Greenville Area AlignLife Offices to do a Thanksgiving in July Food Drive 3Health News:RNS Announces Sessions and Speaker Lineup for the 2015 Annual Conference of the Rheumatology Nurses Society 2Health News:RNS Announces Sessions and Speaker Lineup for the 2015 Annual Conference of the Rheumatology Nurses Society 3Health News:Regional Care, Inc. Retains B. E. Smith to Recruit New President 2Health News:Regional Care, Inc. Retains B. E. Smith to Recruit New President 3Health News:Aurora Product, Inc. Announces An Original New Line: Smoothie Fixins’ 2Health News:First Choice Emergency Room Announces Dr. Mariah N. Manzanares as Medical Director of Frisco, TX Facility 2Health News:First Choice Emergency Room Announces Dr. Mariah N. Manzanares as Medical Director of Frisco, TX Facility 3
... premier meeting for healthcare providers who care for ... as well as sessions on the latest advances ... social, and spiritual aspects of care. , The ... in collaboration with the Hospice and Palliative Nurses ...
... host its 2008 Biodefense and Emerging Diseases Research Meeting ... Hotel in Baltimore, MD. , There is ... the public against not only the traditional agents of ... that hold the potential for serious human and economic ...
... shows that only about half of children diagnosed with ... commonly associated with the condition. , ... is rarely prescribed to treat ADHD, the prevalence and ... in which medication is widely used. ...
... continues its misguided and ineffective assault on NYC,restaurants, ... for,Consumer Freedom (CCF) criticized the New York City ... nutrition labels on their,menus. This morning the Board ... been previously struck down in court., "It ...
... announced it has,expanded both its UPMC for Life ... Life Specialty Plan into Cameron, Clarion,Elk, Forest, and ... of its Medicare PPO (Preferred Provider Organization) into,Clearfield ... Western Pennsylvania helps us continue to,meet the health ...
... especially cardiovascular history, is determining factor, study finds , , ... therapy to radiation treatment for fast-moving prostate cancer can ... men who have other serious medical problems, a new ... is that there definitely is a difference in outcome, ...
Cached Medicine News:Health News:Hospice and palliative care providers unite to discuss 2Health News:2008 ASM Biodefense and Emerging Disease Research Meeting 2Health News:Study raises questions about diagnosis, medical treatment of ADHD 2Health News:Study raises questions about diagnosis, medical treatment of ADHD 3Health News:Consumer Group Criticizes NYC Board of Health Over Menu Labeling Bill 2Health News:UPMC Health Plan Expands Medicare and Special Needs Plan Into Additional Western Pennsylvania Counties 2Health News:Hormone Therapy Only Helps Some Older Men With Prostate Cancer 2
SPIRAL-FLEX® Reinforced Oral/Nasal Cuffed Endotracheal Tubes...
... Monitoring Lumen., ,Designed for neonatal ... endotracheal tube incorporates a monitoring lumen ... which extends to the distal tip. ... line provides convenient connection for CO2 ...
Worlds 1st spray on medical gel lubricant, Sprayglyde was specifically designed to assist the insertion of laryngeal masks....
... the next step in the evolution ... an easy to use, easy to ... as a standard tube, as well ... and safely handle intubations of difficult ...
Medicine Products: